Biotechnology in Italy
Published: August 2013 · Publisher: MarketLine
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017).
- Description
- Companies Mentioned
- Table of Contents
- Ask a Question
Introduction
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
*The Italian biotechnology market had total revenues of $8.0bn in 2012, representing a compound annual growth rate (CAGR) of 7.3% between 2008 and 2012.
*With 248 biotech companies, Italy is third in Europe in terms of company density, following Germany (397) and the United Kingdom (282).
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.6% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $11.1bn by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Italy economy
Key Questions Answered
What was the size of the Italy biotechnology market by value in 2012?
What will be the size of the Italy biotechnology market in 2017?
What factors are affecting the strength of competition in the Italy biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Italy's biotechnology market?
Biotechnology in Italy industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Italy biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Highlights
*The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
*The Italian biotechnology market had total revenues of $8.0bn in 2012, representing a compound annual growth rate (CAGR) of 7.3% between 2008 and 2012.
*With 248 biotech companies, Italy is third in Europe in terms of company density, following Germany (397) and the United Kingdom (282).
*The performance of the market is forecast to decelerate, with an anticipated CAGR of 6.6% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $11.1bn by the end of 2017.
Features
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Italy
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Italy
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Italy biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Italy economy
Key Questions Answered
What was the size of the Italy biotechnology market by value in 2012?
What will be the size of the Italy biotechnology market in 2017?
What factors are affecting the strength of competition in the Italy biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Italy's biotechnology market?
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.
Gentium S.p.A., The Menarini Group and Zambon Company S.p.A.
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Gentium S.p.A. 19
The Menarini Group 22
Zambon Company S.p.A. 24
Macroeconomic Indicators 26
Country Data 26
Appendix 28
Methodology 28
Industry associations 29
Related research 29
LIST OF TABLES
Table 1: Italy biotechnology market value: $ billion, 2008–12 8
Table 2: Italy biotechnology market category segmentation: $ billion, 2012 9
Table 3: Italy biotechnology market geography segmentation: $ billion, 2012 10
Table 4: Italy biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Gentium S.p.A.: key facts 19
Table 6: Gentium S.p.A.: key financials ($) 20
Table 7: Gentium S.p.A.: key financials (€) 20
Table 8: Gentium S.p.A.: key financial ratios 20
Table 9: The Menarini Group: key facts 22
Table 10: The Menarini Group: key financials ($) 23
Table 11: The Menarini Group: key financials (€) 23
Table 12: The Menarini Group: key financial ratios 23
Table 13: Zambon Company S.p.A.: key facts 24
Table 14: Zambon Company S.p.A.: key financials ($) 25
Table 15: Zambon Company S.p.A.: key financials (€) 25
Table 16: Zambon Company S.p.A.: key financial ratios 25
Table 17: Italy size of population (million), 2008–12 26
Table 18: Italy gdp (constant 2000 prices, $ billion), 2008–12 26
Table 19: Italy gdp (current prices, $ billion), 2008–12 26
Table 20: Italy inflation, 2008–12 27
Table 21: Italy consumer price index (absolute), 2008–12 27
Table 22: Italy exchange rate, 2008–12 27
LIST OF FIGURES
Figure 1: Italy biotechnology market value: $ billion, 2008–12 8
Figure 2: Italy biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: Italy biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: Italy biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in Italy, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in Italy, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in Italy, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Italy, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Italy, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in Italy, 2012 18
Figure 11: Gentium S.p.A.: revenues & profitability 21
Figure 12: Gentium S.p.A.: assets & liabilities 21
Executive Summary 2
Market value 2
Market value forecast 2
Category segmentation 2
Geography segmentation 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Category segmentation 9
Geography segmentation 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 14
New entrants 15
Threat of substitutes 17
Degree of rivalry 18
Leading Companies 19
Gentium S.p.A. 19
The Menarini Group 22
Zambon Company S.p.A. 24
Macroeconomic Indicators 26
Country Data 26
Appendix 28
Methodology 28
Industry associations 29
Related research 29
LIST OF TABLES
Table 1: Italy biotechnology market value: $ billion, 2008–12 8
Table 2: Italy biotechnology market category segmentation: $ billion, 2012 9
Table 3: Italy biotechnology market geography segmentation: $ billion, 2012 10
Table 4: Italy biotechnology market value forecast: $ billion, 2012–17 11
Table 5: Gentium S.p.A.: key facts 19
Table 6: Gentium S.p.A.: key financials ($) 20
Table 7: Gentium S.p.A.: key financials (€) 20
Table 8: Gentium S.p.A.: key financial ratios 20
Table 9: The Menarini Group: key facts 22
Table 10: The Menarini Group: key financials ($) 23
Table 11: The Menarini Group: key financials (€) 23
Table 12: The Menarini Group: key financial ratios 23
Table 13: Zambon Company S.p.A.: key facts 24
Table 14: Zambon Company S.p.A.: key financials ($) 25
Table 15: Zambon Company S.p.A.: key financials (€) 25
Table 16: Zambon Company S.p.A.: key financial ratios 25
Table 17: Italy size of population (million), 2008–12 26
Table 18: Italy gdp (constant 2000 prices, $ billion), 2008–12 26
Table 19: Italy gdp (current prices, $ billion), 2008–12 26
Table 20: Italy inflation, 2008–12 27
Table 21: Italy consumer price index (absolute), 2008–12 27
Table 22: Italy exchange rate, 2008–12 27
LIST OF FIGURES
Figure 1: Italy biotechnology market value: $ billion, 2008–12 8
Figure 2: Italy biotechnology market category segmentation: % share, by value, 2012 9
Figure 3: Italy biotechnology market geography segmentation: % share, by value, 2012 10
Figure 4: Italy biotechnology market value forecast: $ billion, 2012–17 11
Figure 5: Forces driving competition in the biotechnology market in Italy, 2012 12
Figure 6: Drivers of buyer power in the biotechnology market in Italy, 2012 13
Figure 7: Drivers of supplier power in the biotechnology market in Italy, 2012 14
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Italy, 2012 15
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Italy, 2012 17
Figure 10: Drivers of degree of rivalry in the biotechnology market in Italy, 2012 18
Figure 11: Gentium S.p.A.: revenues & profitability 21
Figure 12: Gentium S.p.A.: assets & liabilities 21
Copyright © FriedlNet. You may share using our tools Please don't cut content from FriedlNet and redistribute by email or post to the web.